Antibiotic sensitivity of endemic shigella in Mbarara, Uganda

East African Medical Journal

Volumn 75, Issue 3, 1998, Pages 160-161

  Legros, D ^a   Ochola, D ^b   Lwanga, N ^c   Guma, G ^b  

^a EPICENTRE   (France)

^b MINISTRY OF HEALTH   (Uganda)

^c Mbarara University   (Uganda)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; CIPROFLOXACIN; COTRIMOXAZOLE; MECILLINAM; NALIDIXIC ACID; NORFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ADOLESCENT; ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; CHILD; CLINICAL ARTICLE; DYSENTERY; ENDEMIC DISEASE; FEMALE; HUMAN; INFANT; MALE; SHIGELLA; UGANDA;

ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; DRUG RESISTANCE, MICROBIAL; DYSENTERY, BACILLARY; ENDEMIC DISEASES; FECES; FEMALE; HUMANS; INFANT; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; UGANDA;

SHIGELLA;

EID: 0031863943     PISSN: 0012835X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Cobra, C and Sack, D. A. Strategic response to epidemic dysentery in Africa. Department of International Health, School of Hygiene and of Public Health, John Hopkins University, Baltimore, USA. 1994; 74p.
2. Keush, G.T. and Bennish, M.L. Shigellosis: recent progress, persisting problems and research issues. Paediat. Infect. Dis. J. 1989; 8:713-719.
3. Review of the dysentery situation in Uganda. Control of Diarrhoeal Disease Programme. Ministry of Health, Entebbe, Uganda, February, 1995.
4. Bennish, M.L., Salam, M.A., Haider, R. Barza, M. Therapy for Shigellosis. II. Randomised, double blind comparison of ciprofloxacin and ampicillin. J. Infect. Dis. 1990; 162:711-716.
5. WHO Guidelines for the control of epidemics due to Shigella dysenteriae type 1. WHO. Geneva, 1988; publication no. SER/ 88.12.